珈凯生物
(920165)
| 流通市值：4.32亿 | | | 总市值：12.47亿 |
| 流通股本：1671.40万 | | | 总股本：4827.44万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 221,519,002.09 | 151,131,040.55 | 74,949,661.97 | 262,659,452.34 |
| 营业总成本 | 161,480,120.57 | 108,318,089.38 | 52,787,232.97 | 191,607,475.3 |
| 其他经营收益 | | | | |
| 营业利润 | 61,595,730.24 | 43,666,249.61 | 21,935,217.63 | 76,695,512.72 |
| 利润总额 | 61,479,577.74 | 43,611,116.51 | 21,879,718.79 | 76,500,749.4 |
| 净利润 | 53,093,245.41 | 37,571,648.64 | 19,303,319.95 | 66,269,289.72 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 53,093,245.41 | 37,571,648.64 | 19,303,319.95 | 66,269,289.72 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 345,913,963.02 | 240,965,391.77 | 217,280,907 | 192,188,708.5 |
| 非流动资产: | | | | |
| 非流动资产合计 | 284,860,524 | 289,644,338.18 | 295,967,810.23 | 299,951,210.09 |
| 资产总计 | 630,774,487.02 | 530,609,729.95 | 513,248,717.23 | 492,139,918.59 |
| 流动负债: | | | | |
| 流动负债合计 | 33,555,161.2 | 35,441,648.57 | 36,917,944.65 | 36,285,362.75 |
| 非流动负债: | | | | |
| 非流动负债合计 | 14,480,125.16 | 14,058,763.85 | 14,237,806.32 | 13,812,932.11 |
| 负债合计 | 48,035,286.36 | 49,500,412.42 | 51,155,750.97 | 50,098,294.86 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 582,739,200.66 | 481,109,317.53 | 462,092,966.26 | 442,041,623.73 |
| 股东权益合计 | 582,739,200.66 | 481,109,317.53 | 462,092,966.26 | 442,041,623.73 |
| 负债和股东权益合计 | 630,774,487.02 | 530,609,729.95 | 513,248,717.23 | 492,139,918.59 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 243,195,471.93 | 173,602,016.17 | 78,678,657.87 | 301,109,326.86 |
| 经营活动现金流出小计 | 192,144,208.79 | 131,786,107.92 | 63,254,047.62 | 209,580,089.1 |
| 经营活动产生的现金流量净额 | 51,051,263.14 | 41,815,908.25 | 15,424,610.25 | 91,529,237.76 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 572,080,759.75 | 391,806,218.27 | 190,349,325.69 | 378,564,284.9 |
| 投资活动现金流出小计 | 658,220,655.73 | 366,258,749.73 | 163,639,730.35 | 452,937,617.05 |
| 投资活动产生的现金流量净额 | -86,139,895.98 | 25,547,468.54 | 26,709,595.34 | -74,373,332.15 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 127,610,115.2 | - | - | - |
| 筹资活动现金流出小计 | 39,141,027.98 | 908,141.34 | 678,279 | 36,174,671.99 |
| 筹资活动产生的现金流量净额 | 88,469,087.22 | -908,141.34 | -678,279 | -36,174,671.99 |
| 汇率变动对现金及现金等价物的影响 | -2,946.79 | -650,182.65 | -228,122.24 | 83,978.91 |
| 现金及现金等价物净增加额 | 53,377,507.59 | 65,805,052.8 | 41,227,804.35 | -18,934,787.47 |
| 期末现金及现金等价物余额 | 112,374,023.42 | 124,801,568.63 | 100,224,320.18 | 58,996,515.83 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 65,805,052.8 | - | -18,934,787.47 |